HERON ELAINE J
Insider CIK 1235471 · BMRN Director · PVLA Director · VXRT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VXRT Vaxart, Inc. | A Award deriv | 2026-07-16 | 2026-07-17 | 78,700 | — | $0 | 78,700 | SEC↗ |
| VXRT Vaxart, Inc. | A Award | 2026-07-16 | 2026-07-17 | 39,400 | — | $0 | 135,966 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | A Award deriv | 2026-06-10 | 2026-06-12 | 3,000 | — | $0 | 3,000 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | P Buy | 2026-02-27 | 2026-03-02 | 2,400 | $125.00 | $300.0K | 47,812 | SEC↗ |
| VXRT Vaxart, Inc. | P Buy | 2025-11-17 | 2025-11-21 | 16,783 | $0.41 | $6.9K | 96,566 | SEC↗ |
| VXRT Vaxart, Inc. | P Buy | 2025-11-17 | 2025-11-21 | 23,217 | $0.39 | $9.1K | 79,783 | SEC↗ |
| VXRT Vaxart, Inc. | A Award deriv | 2025-06-13 | 2025-06-16 | 95,400 | — | $0 | 95,400 | SEC↗ |
| VXRT Vaxart, Inc. | A Award | 2025-06-13 | 2025-06-16 | 16,000 | — | $0 | 56,566 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | A Award deriv | 2025-06-10 | 2025-06-11 | 12,350 | — | $0 | 12,350 | SEC↗ |
| PVLA PALVELLA THERAPEUTICS, INC | A Award deriv | 2024-12-13 | 2024-12-17 | 24,700 | — | $0 | 24,700 | SEC↗ |
| VXRT Vaxart, Inc. | A Award deriv | 2024-06-11 | 2024-06-12 | 95,400 | — | $0 | 95,400 | SEC↗ |
| VXRT Vaxart, Inc. | A Award | 2024-06-11 | 2024-06-12 | 16,000 | — | $0 | 40,566 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2024-06-03 | 2024-06-04 | 5,047 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2024-06-03 | 2024-06-04 | 5,047 | $63.10 | $318.5K | 101,888 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2024-06-03 | 2024-06-04 | 4,168 | $76.41 | $318.5K | 97,720 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2024-05-21 | 2024-05-23 | 4,720 | — | $0 | 96,841 | SEC↗ |
| VXRT Vaxart, Inc. | A Award deriv | 2023-06-26 | 2023-08-01 | 41,510 | — | $0 | 41,510 | SEC↗ |
| VXRT Vaxart, Inc. | A Award | 2023-06-26 | 2023-08-01 | 6,922 | — | $0 | 24,566 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2023-05-23 | 2023-05-24 | 4,190 | — | $0 | 92,121 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2023-05-12 | 2023-05-17 | 8,500 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | F Tax w/h | 2023-05-12 | 2023-05-17 | 6,137 | $93.93 | $576.4K | 87,931 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2023-05-12 | 2023-05-17 | 8,500 | $67.81 | $576.4K | 94,068 | SEC↗ |
| VXRT Vaxart, Inc. | A Award deriv | 2022-08-25 | 2022-08-25 | 88,448 | — | $0 | 88,448 | SEC↗ |
| VXRT Vaxart, Inc. | A Award | 2022-08-25 | 2022-08-25 | 14,750 | — | $0 | 17,644 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2022-05-24 | 2022-05-26 | 4,980 | — | $0 | 85,568 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2022-02-25 | 2022-02-28 | 8,500 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2022-02-25 | 2022-02-28 | 8,500 | $37.46 | $318.4K | 80,588 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2021-05-25 | 2021-05-27 | 5,120 | — | $0 | 72,088 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2020-10-07 | 2020-10-08 | 15,000 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2020-10-07 | 2020-10-08 | 15,000 | $26.49 | $397.4K | 66,968 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2020-05-27 | 2020-05-29 | 4,300 | — | $0 | 51,968 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2019-08-07 | 2019-08-08 | 1,553 | — | $0 | 5,047 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2019-08-07 | 2019-08-08 | 1,553 | $63.10 | $98.0K | 47,668 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2019-06-04 | 2019-06-06 | 4,430 | — | $0 | 46,115 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2018-09-05 | 2018-09-07 | 1,000 | $96.94 | $96.9K | 41,685 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2018-06-05 | 2018-06-07 | 4,300 | — | $0 | 42,685 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2017-12-14 | 2017-12-18 | 800 | $88.90 | $71.1K | 38,385 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2017-06-06 | 2017-06-08 | 4,910 | — | $0 | 4,910 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2017-06-06 | 2017-06-08 | 2,050 | — | $0 | 39,185 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2016-06-06 | 2016-06-08 | 4,440 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-06-06 | 2016-06-08 | 1,510 | — | $0 | 37,135 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2015-09-08 | 2015-09-25 | 15,000 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2015-09-08 | 2015-09-25 | 15,000 | $21.51 | $322.6K | 35,625 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2015-06-10 | 2015-06-18 | 3,300 | — | $0 | 3,300 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2015-06-10 | 2015-06-18 | 1,100 | — | $0 | 20,625 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2014-06-04 | 2014-06-06 | 6,600 | — | $0 | 6,600 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2014-06-04 | 2014-06-06 | 2,100 | — | $0 | 19,525 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2013-05-15 | 2013-05-17 | 8,500 | — | $0 | 8,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2013-05-15 | 2013-05-17 | 3,400 | — | $0 | 17,425 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-11-12 | 2012-11-13 | 300 | $48.35 | $14.5K | 14,025 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-11-12 | 2012-11-13 | 1,575 | $48.32 | $76.1K | 14,325 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-11-09 | 2012-11-09 | 30,000 | $48.01 | $1.44M | 15,900 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-11-07 | 2012-11-09 | 30,000 | — | $0 | 113,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-11-07 | 2012-11-09 | 30,000 | — | $0 | 83,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-11-07 | 2012-11-09 | 15,000 | — | $0 | 68,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-11-07 | 2012-11-09 | 15,000 | — | $0 | 53,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-11-07 | 2012-11-09 | 15,000 | — | $0 | 38,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-07 | 2012-11-09 | 30,000 | $14.93 | $447.9K | 105,900 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-11-07 | 2012-11-09 | 105,000 | $46.44 | $4.88M | 45,900 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-07 | 2012-11-09 | 15,000 | $14.39 | $215.8K | 150,900 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-07 | 2012-11-09 | 30,000 | $7.46 | $223.8K | 75,900 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-07 | 2012-11-09 | 15,000 | $17.33 | $259.9K | 120,900 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-11-07 | 2012-11-09 | 15,000 | $38.59 | $578.9K | 135,900 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2012-05-08 | 2012-05-10 | 8,500 | — | $0 | 143,500 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-05-08 | 2012-05-10 | 3,400 | — | $0 | 45,900 | SEC↗ |